Business Context and Reporting Period
This Form 8-K filing by Diebold Nixdorf, Inc. (DBD) reports on events occurring on January 19, 2024. The filing details the approval and authorization of equity compensation grants to executive officers under the company's 2023 Equity and Incentive Plan.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements.
Material Changes and Equity Grants
On January 19, 2024, the Board of Directors and the People and Compensation Committee approved grants of stock options and restricted stock units (RSUs) to six executive officers. The exercise price for the options was set at $30.90, reflecting the closing stock price on the grant date.
- Octavio Marquez (CEO): 250,443 Options and 50,088 RSUs.
- James Barna (CFO): 40,696 Options and 8,139 RSUs.
- Ilhami Cantadurucu (EVP, Global Retail): 40,696 Options and 8,139 RSUs.
- Jonathan Myers (EVP, Global Banking): 62,610 Options and 12,522 RSUs.
- Elizabeth Christine Radigan (EVP, CLO): 40,696 Options and 8,139 RSUs.
- Frank Baur (EVP, Operational Excellence): 40,696 Options and 8,139 RSUs.
Terms, Vesting, and Risks
Option Vesting Terms: Options generally vest on the fourth anniversary of the grant date, contingent on continued employment. Vesting is performance-based, split into three tranches (40%, 30%, 30%) tied to 20-day trading average price hurdles of $65.00, $85.00, and $95.00, respectively. Unearned tranches are forfeited if hurdles are not met. The options have a 10-year term.
RSU Vesting Terms: RSUs vest ratably in equal annual installments over four years, subject to continued employment. Dividend equivalents accrue but are paid only upon vesting and settlement.
Risks and Contingencies: Awards may be forfeited if the awardee engages in detrimental activity. Alternative vesting treatments apply in the event of a change in control, death, disability, or certain involuntary terminations.
Investor Verification Checklist
- Verify the current stock price relative to the $30.90 exercise price and the $65.00, $85.00, and $95.00 performance hurdles.
- Review the specific "detrimental activity" clauses in the award agreements that could trigger forfeiture.
- Monitor future filings for any changes in executive employment status that could impact vesting schedules.
- Assess the dilution impact of the total 465,837 options and 95,567 RSUs granted.